TABRECTA
Novartis Ag
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79148570 |
| Registration Number | 4630489 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | M60 |
| Employee Name | ROACH, APRIL K |
Timeline
| 2014-03-21 | Application Filed |
| 2014-08-19 | Published for Opposition |
| 2014-11-04 | Location: PUBLICATION AND ISSUE SECTION |
| 2014-11-04 | Status: Live/Registered |
| 2014-11-04 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  NOVARTIS AG |
| Entity Statement | Aktiengesellschaft |
| Address | CH-4002 Basel CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genito-urinary system, for treatment of inflammatory disorders, for use in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastro-enterological disorders; pharmaceutical products for the treatment of ocular disorders or diseases, for the treatment of bacterial diseases, and for the treatment of diabetes; anti-infective products, antiviral products, antibiotics, anti-fungal products |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2014-07-03 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2014-07-07 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-07-10 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-07-10 | 4 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-07-14 | 5 CNSA O:Outgoing Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2014-07-15 | 6 MAFR O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2014-07-30 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2014-08-19 | 8 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2014-11-04 | 9 R.PR A:Allowance for Publication |
| GRANT OF PROTECTION CREATED, TO BE SENT TO IB | 2014-12-04 | 10 GPAR P: |
| FINAL DISPOSITION PROCESSED | 2015-01-26 | 11 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2015-01-26 | 12 FICS P: |
| NOTIFICATION PROCESSED BY IB | 2015-02-13 | 13 GPNX P: |
| DEATH OF INTERNATIONAL REGISTRATION | 2020-02-21 | 14 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2020-02-21 | 15 DENC O:Outgoing Correspondence |
| NOTIFICATION PROCESSED BY IB | 2020-10-10 | 16 GPNX P: |
| INTERNATIONAL REGISTRATION RENEWED | 2023-12-08 | 17 RNWL P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TABRECTA 79281021 not registered Live/Pending |
NOVARTIS AG 2020-01-22 |
 TABRECTA 79148570 4630489 Live/Registered |
NOVARTIS AG 2014-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 